Previous studies show that TTN mutation is related to high immunogenicity and inflammatory tumor immune microenvironment in lung adenocarcinoma, accompanied by favorable objective response and survival with ICI administration [51, 52]. Here, TTN is linked to lung adenocarcinoma.